Dr. Sklar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
310 Cedar St
Lauder Hall, Room 108
New Haven, CT 06510Phone+1 203-785-3624Fax+1 203-785-7037
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1977 - 1981
- Yale School of MedicineClass of 1977
Certifications & Licensure
- CT State Medical License 2003 - 2021
Publications & Presentations
PubMed
- 3 citationsNCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.Michael Cecchini, James M Cleary, Yu Shyr, Joseph Chao, Nataliya Uboha
British Journal of Cancer. 2024-02-01 - 1 citationsQuantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer.Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey Sklar, Jill Lacy
Cancer Research Communications. 2023-06-01 - 3 citationsDeletion ofgene causes early growth retardation and insulin resistance in mice.Hui-Young Lee, Hye Rim Jang, Hui Li, Varman T Samuel, Karrie D Dudek
Proceedings of the National Academy of Sciences of the United States of America. 2022-12-06
Press Mentions
- Precipio and Transgenomic Announce Experts from Yale and Harvard Joining New Scientific Advisory Board to Support Merged Company’s Growth InitiativesJune 16th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: